EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An HIV-1/HIV-2 Chimeric Envelope Glycoprotein Generates Binding and Neutralising Antibodies against HIV-1 and HIV-2 Isolates

Nuno Taveira iD, Inês Figueiredo, Rita Calado, Francisco Martin, Inês Bártolo iD, José M Marcelino, Pedro Borrego iD, Fernando Cardoso iD, Helena Barroso iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24109077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Nuno Taveira und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), Egas Moniz School of Health and Science, 2829-511 Caparica, Portugal. Hauptthemen laut MEDLINE: HIV-1. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Portugal, and Aga Khan Development Network (AKDN) - Portugal Collaborative Research Network in Portuguese speaking countr…, Ministry of Health, Portugal, This work was funded by national funds through the FCT - Foundation for Science and Technology, I.P.,.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of immunogens that elicit broadly reactive neutralising antibodies (bNAbs) is the highest priority for an HIV vaccine. We have shown that a prime-boost vaccination strategy with vaccinia virus expressing the envelope glycoprotein gp120 of HIV-2 and a polypeptide comprising the envelope regions C2, V3 and C3 elicits bNAbs against HIV-2. We hypothesised that a chimeric envelope gp120 containing the C2, V3 and C3 regions of HIV-2 and the remaining parts of HIV-1 would elicit a neutralising response against HIV-1 and HIV-2. This chimeric envelope was synthesised and expressed in vaccinia virus. Balb/c mice primed with the recombinant vaccinia virus and boosted with an HIV-2 C2V3C3 polypeptide or monomeric gp120 from a CRF01_AG HIV-1 isolate produced antibodies that neutralised >60% (serum dilution 1:40) of a primary HIV-2 isolate. Four out of nine mice also produced antibodies that neutralised at least one HIV-1 isolate. Neutralising epitope specificity was assessed using a panel of HIV-1 TRO.11 pseudoviruses with key neutralising epitopes disrupted by alanine substitution (N160A in V2; N278A in the CD4 binding site region; N332A in the high mannose patch). The neutralisation of the mutant pseudoviruses was reduced or abolished in one mouse, suggesting that neutralising antibodies target the three major neutralising epitopes in the HIV-1 envelope gp120. These results provide proof of concept for chimeric HIV-1/HIV-2 envelope glycoproteins as vaccine immunogens that can direct the antibody response against neutralising epitopes in the HIV-1 and HIV-2 surface glycoproteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1AnimalsMiceHIV-2HIV AntibodiesBroadly Neutralizing AntibodiesAntibodies, NeutralizingEpitopesVaccinia virusGlycoproteinsHIV Envelope Protein gp120

Stichwörter der Autor:innen

HIV vaccinechimeric envelope glycoproteinsneutralizing antibodiesneutralizing epitopesvaccinia virus

Substanzen

HIV AntibodiesBroadly Neutralizing AntibodiesAntibodies, NeutralizingEpitopesGlycoproteinsHIV Envelope Protein gp120

Autor:innen und Institutionen

  • Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), Egas Moniz School of Health and Science, 2829-511 Caparica, Portugal.
  • Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon, 1649-003 Lisboa, Portugal.
  • Centre for Public Administration and Public Policies, Institute of Social and Political Sciences, Universidade de Lisboa, 1300-663 Lisbon, Portugal.
  • Unidade de Microbiologia Médica, Saúde Global e Medicina Tropical, Instituto de Higiene e Medicina Tropical, Universidade NOVA de Lisboa, 1099-085 Lisbon, Portugal.

ORCID-Profile: Nuno Taveira, Inês Bártolo, Pedro Borrego, Fernando Cardoso, Helena Barroso

Förderung

  • Fundação para a Ciência e Tecnologia, Portugal, and Aga Khan Development Network (AKDN) - Portugal Collaborative Research Network in Portuguese speaking countr…
  • Ministry of Health, Portugal
  • This work was funded by national funds through the FCT - Foundation for Science and Technology, I.P.,
  • national funds
  • FCT and Aga Khan Development Network (AKDN)—Portugal Collaborative Research Network
  • Ministry of Health

Zitieren

APA

Taveira, N., Figueiredo, I., Calado, R., Martin, F., Bártolo, I., Marcelino, J. M., Borrego, P., Cardoso, F., & Barroso, H. (2023). An HIV-1/HIV-2 Chimeric Envelope Glycoprotein Generates Binding and Neutralising Antibodies against HIV-1 and HIV-2 Isolates. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24109077

Vancouver

Taveira N, Figueiredo I, Calado R, Martin F, Bártolo I, Marcelino JM, et al. An HIV-1/HIV-2 Chimeric Envelope Glycoprotein Generates Binding and Neutralising Antibodies against HIV-1 and HIV-2 Isolates. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24109077

BibTeX
@article{Taveira2023,
  author = {Taveira, Nuno and Figueiredo, Inês and Calado, Rita and Martin, Francisco and Bártolo, Inês and Marcelino, José M and Borrego, Pedro and Cardoso, Fernando and Barroso, Helena},
  title = {An HIV-1/HIV-2 Chimeric Envelope Glycoprotein Generates Binding and Neutralising Antibodies against HIV-1 and HIV-2 Isolates},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24109077}
}
Kostenlos starten →